BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 31388051)

  • 1. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.
    Conserva F; Barozzino M; Pesce F; Divella C; Oranger A; Papale M; Sallustio F; Simone S; Laviola L; Giorgino F; Gallone A; Pontrelli P; Gesualdo L
    Sci Rep; 2019 Aug; 9(1):11357. PubMed ID: 31388051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy.
    An Y; Zhang C; Xu F; Li W; Zeng C; Xie L; Liu Z
    Nephrol Dial Transplant; 2020 Jun; 35(6):1009-1016. PubMed ID: 30521014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA lnc-ISG20 promotes renal fibrosis in diabetic nephropathy by inducing AKT phosphorylation through miR-486-5p/NFAT5.
    Duan YR; Chen BP; Chen F; Yang SX; Zhu CY; Ma YL; Li Y; Shi J
    J Cell Mol Med; 2021 Jun; 25(11):4922-4937. PubMed ID: 33939247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs.
    Yu J; Yu C; Feng B; Zhan X; Luo N; Yu X; Zhou Q
    BMC Nephrol; 2019 Aug; 20(1):336. PubMed ID: 31455266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
    Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
    Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
    PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
    Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
    Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the 'Asian Indian phenotype'.
    Prabu P; Rome S; Sathishkumar C; Gastebois C; Meugnier E; Mohan V; Balasubramanyam M
    Diabetes Metab; 2019 Jun; 45(3):276-285. PubMed ID: 30165157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy.
    Pontrelli P; Conserva F; Papale M; Oranger A; Barozzino M; Vocino G; Rocchetti MT; Gigante M; Castellano G; Rossini M; Simone S; Laviola L; Giorgino F; Grandaliano G; Di Paolo S; Gesualdo L
    FASEB J; 2017 Jan; 31(1):308-319. PubMed ID: 27881486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.
    Cardenas-Gonzalez M; Srivastava A; Pavkovic M; Bijol V; Rennke HG; Stillman IE; Zhang X; Parikh S; Rovin BH; Afkarian M; de Boer IH; Himmelfarb J; Waikar SS; Vaidya VS
    Clin Chem; 2017 Sep; 63(9):1515-1526. PubMed ID: 28667184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy.
    Li W; Yang S; Qiao R; Zhang J
    Clin Lab; 2018 May; 64(5):709-718. PubMed ID: 29739042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
    Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
    Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease.
    Xie Y; Jia Y; Cuihua X; Hu F; Xue M; Xue Y
    J Diabetes Res; 2017; 2017():6978984. PubMed ID: 29038788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy.
    Levstek T; Mlinšek T; Holcar M; Goričar K; Lenassi M; Dolžan V; Vujkovac B; Trebušak Podkrajšek K
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease.
    Mishra DD; Sahoo B; Maurya PK; Sharma R; Varughese S; Prasad N; Tiwari S
    Front Endocrinol (Lausanne); 2023; 14():1157194. PubMed ID: 37251672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
    Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Lysine 63 Ubiquitination Prevents the Progression of Renal Fibrosis in Diabetic DBA/2J Mice.
    Pontrelli P; Conserva F; Menghini R; Rossini M; Stasi A; Divella C; Casagrande V; Cinefra C; Barozzino M; Simone S; Pesce F; Castellano G; Stallone G; Gallone A; Giorgino F; Federici M; Gesualdo L
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.
    Gholaminejad A; Abdul Tehrani H; Gholami Fesharaki M
    J Nephrol; 2018 Dec; 31(6):813-831. PubMed ID: 30019103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy.
    Wang X; Xu Y; Zhu YC; Wang YK; Li J; Li XY; Ji T; Bai SJ
    J Cell Physiol; 2019 Aug; 234(8):12926-12933. PubMed ID: 30549040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.